COST-EFFECTIVENESS ANALYSIS OF BENDAMUSTINE PLUS RITUXIMAB AS FIRST-LINE TREATMENT FOR PATIENTS WITH FOLLICULAR LYMPHOMA. PRELIMINARY RESULTS

被引：0
|
作者：
Sabater, E. [1 ]
Rueda, A. [2 ]
Salar, A. [3 ]
Lopez-Guillermo, A. [4 ]
Oyagueez, I. [1 ]
Collar, J. M. [5 ]
机构：
[1] Pharmacoecon & Outcomes Res Iberia, Madrid, Spain
[2] Hosp Costa del Sol, Dept Oncol, Marbella, Spain
[3] Hosp del Mar, Hematol Dept, Madrid, Spain
[4] Hosp Clin Barcelona, Hematol Dept, Barcelona, Spain
[5] Mundipharma Pharmaceut, Dept Med, Madrid, Spain
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1270
引用
收藏
页码：487 / 488
页数：2
相关论文
共 50 条
  • [21] Cost-Effectiveness Analysis of Maintenance Therapy with Rituximab in Patients with Follicular Lymphoma Responding to Induction Therapy at the First Line
    Castro Gomez, Antonio J.
    Lopez-Guillermo, Armando
    Rueda Dominguez, Antonio
    Salar, Antonio
    Varela Moreno, Cristina
    Rubio-Terres, Carlos
    REVISTA ESPANOLA DE SALUD PUBLICA, 2012, 86 (02): : 163 - 176
  • [22] Cost-effectiveness of obinutuzumab plus bendamustine in Chinese patients with relapse and refractory follicular lymphoma
    Ma, Jun
    Zhao, Donglu
    Zhen, Bihong
    Xia, Yan
    Gong, Qianyi
    Chen, Wendong
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2023, 12 (12)
  • [23] An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK
    Ray, Joshua A.
    Carr, Emma
    Lewis, Gavin
    Marcus, Robert
    VALUE IN HEALTH, 2010, 13 (04) : 346 - 357
  • [24] Cost-effectiveness of rituximab in follicular lymphoma
    Johnston, Karissa M.
    Bolbocean, Corneliu
    Connors, Joseph
    Peacock, Stuart
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (05) : 569 - 577
  • [25] Comparing the Cost-Effectiveness of Rituximab Maintenance and Radioimmunotherapy Consolidation versus Observation Folio First-Line Therapy in Patients with Follicular Lymphoma
    Chen, Qiushi
    Ayer, Turgay
    Nastoupil, Loretta J.
    Rose, Adam C.
    Flowers, Christopher R.
    VALUE IN HEALTH, 2015, 18 (02) : 189 - 197
  • [26] Assessment of Maintenance Rituximab after First-Line Bendamustine-Rituximab in Patients with Follicular Lymphoma: An Analysis from the BRIGHT Trial
    Kahl, Brad S.
    Burke, John M.
    van der Jagt, Richard
    Chang, Julie
    Wood, Peter
    Hawkins, Tim
    MacDonald, David
    Trotman, Judith
    Simpson, David
    Kolibaba, Kathryn S.
    Issa, Samar
    Hallman, Doreen
    Chen, Ling
    Flinn, Ian W.
    BLOOD, 2017, 130
  • [27] Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden
    Kasteng, Frida
    Erlanson, Martin
    Hagberg, Hans
    Kimby, Eva
    Relander, Thomas
    Lundkvist, Jonas
    ACTA ONCOLOGICA, 2008, 47 (06) : 1029 - 1036
  • [28] RADIOTHERAPY PLUS RITUXIMAB AS FIRST-LINE REGIMEN FOR LOCALIZED FOLLICULAR LYMPHOMA
    Cencini, E.
    Puccini, B.
    Rigacci, L.
    Fabbri, A.
    Kovalchuk, S.
    Mannelli, L.
    Benelli, G.
    Carfagno, T.
    Simontacchi, G.
    Bocchia, M.
    Bosi, A.
    HAEMATOLOGICA, 2017, 102 : 108 - 109
  • [29] Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma
    Cencini, Emanuele
    Puccini, Benedetta
    Rigacci, Luigi
    Fabbri, Alberto
    Kovalchuk, Sofia
    Mannelli, Lara
    Benelli, Gemma
    Carfagno, Tommaso
    Simontacchi, Gabriele
    Bocchia, Monica
    Bosi, Alberto
    LEUKEMIA & LYMPHOMA, 2018, 59 (06) : 1420 - 1426
  • [30] High Risk of Transformation and Secondary Malignancies in Follicular Lymphoma Patients Treated With First-line Bendamustine Rituximab and Rituximab Maintenance
    Rangel-Patino, Juan
    Kridel, Robert
    Kuruvilla, John
    Prica, Anca
    Kukreti, Vishal
    Bhella, Sita
    Delabie, Jan
    Vijenthira, Abi
    Crump, Michael
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S503 - S503
12345